<DOC>
	<DOCNO>NCT00512408</DOCNO>
	<brief_summary>Background : Patients congestive heart failure ( CHF ) show muscle mass waste decrease testosterone level . Long-term testosterone supplementation improve walk distance glucose metabolism patient CHF . No study investigate integrated effect testosterone exercise oxygen uptake muscle strength glucose metabolism patient CHF regardless presence hypogonadism . Aim : To assess effect 12 week testosterone administration maximal exercise capacity , muscle strength insulin resistance elderly CHF patient . Methods : Seventy elderly patient stable CHF , mean age 71 ± 8 year , ejection fraction 34 ± 1 % , NYHA class II/III 38/32 , enrol . Of , 35 randomize receive testosterone therapy ( intramuscular injection every 6 week ) 35 receive placebo top maximal medical therapy . At baseline 12 week patient underwent echocardiogram , cardiopulmonary test , 6-minute walk test ( 6MWT ) , quadriceps maximal isometric isokinetic strength .</brief_summary>
	<brief_title>Testosterone Improves Exercise Oxygen Uptake , Insulin Resistance Muscle Strength Elderly Patients With Chronic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>leave ventricular ejection fraction ( LVEF ) &lt; 40 % ; New York Heart Association ( NYHA ) class II III ; clinical stability without hospital admission heart failure previous 3 month . unstable angina recent acute myocardial infarction , history severe liver diseases history severe kidney disease uncontrolled hypertension erythrocytosis ( hematocrit &gt; 50 % ) hyperviscosity prostate cancer , prostatespecific antigen ( PSA ) great 3 ng/ml severe low urinary tract symptom .</criteria>
	<gender>Male</gender>
	<minimum_age>56 Years</minimum_age>
	<maximum_age>76 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>To assess effect 12 week testosterone administration maximal exercise capacity , muscle strength insulin resistance elderly CHF patient</keyword>
</DOC>